Imlygic Interactions
There are 300 drugs known to interact with Imlygic (talimogene laherparepvec), along with 4 disease interactions. Of the total drug interactions, 281 are major, and 19 are moderate.
- View all 300 medications that may interact with Imlygic
- View Imlygic disease interactions (4)
Most frequently checked interactions
View interaction reports for Imlygic (talimogene laherparepvec) and the medicines listed below.
- Actemra (tocilizumab)
- Adriamycin (doxorubicin)
- Amicar (aminocaproic acid)
- Aricept (donepezil)
- atorvastatin
- Avastin (bevacizumab)
- Banzel (rufinamide)
- Baraclude (entecavir)
- bleomycin
- Blincyto (blinatumomab)
- chloramphenicol
- Clozaril (clozapine)
- Corlanor (ivabradine)
- Coumadin (warfarin)
- Cresemba (isavuconazonium)
- cyclophosphamide
- Cymbalta (duloxetine)
- Diflucan (fluconazole)
- Epidiolex (cannabidiol)
- Farydak (panobinostat)
- Genvoya (cobicistat / elvitegravir / emtricitabine / tenofovir alafenamide)
- Imbruvica (ibrutinib)
- Imuran (azathioprine)
- Isentress (raltegravir)
- Jadenu Sprinkle (deferasirox)
- Kalydeco (ivacaftor)
- Lamictal (lamotrigine)
- midazolam
- Natrecor (nesiritide)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil)
Imlygic disease interactions
There are 4 disease interactions with Imlygic (talimogene laherparepvec) which include:
Report options
More about Imlygic (talimogene laherparepvec)
- Imlygic consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Tecentriq
Tecentriq (atezolizumab) is a monoclonal antibody used to treat non-small cell lung cancer, small ...
Yervoy
Yervoy (ipilimumab) is a cancer treatment used for lung cancer, melanoma, renal cell carcinoma ...
Mekinist
Mekinist is used to treat melanoma, non-small cell lung cancer, thyroid cancer, solid tumors, and ...
Braftovi
Braftovi is a targeted cancer treatment used in combination with Mektovi, mFOLFOX6, or Erbitux, to ...
Interferon alfa-2b
Interferon alfa-2b systemic is used for angioblastoma, condylomata acuminata, conjunctival ...
Dacarbazine
Dacarbazine systemic is used for hodgkin's lymphoma, melanoma, melanoma, metastatic
Ipilimumab
ipilimumab (Yervoy) is an immunotherapy used for melanoma, renal cell carcinoma, non-small cell ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.